These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6172136)

  • 1. On the mutagenicity and immunogenicity of a beta-propiolactone-treated therapeutic IgG-preparation.
    Pincus JH; Mortelmans K; Tanaka W; Stephan W; Lissner R
    Arzneimittelforschung; 1981; 31(11):1924-8. PubMed ID: 6172136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical study of the tolerance and safety of a beta-propiolactone-treated immunoglobulin.
    Mondorf AW; Stephan W; Uthemann H; Schuppan D; Lissner R
    Arzneimittelforschung; 1981; 31(11):1928-30. PubMed ID: 6797445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations].
    Stephan W; Dichtelmüller H
    Arzneimittelforschung; 1983; 33(9):1230-1. PubMed ID: 6416260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental transfer of class G immunoglobulins treated with beta-propiolactone (beta-PL) for intravenous application--a case report.
    Höckel M; Kaufmann R
    J Perinat Med; 1986; 14(3):205-8. PubMed ID: 3783391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human i.v. immune globulin by chemical modification with beta-propiolactone/radiochemical study (author's transl)].
    Stephan W; Fasold H
    Arzneimittelforschung; 1980; 30(12):2090-3. PubMed ID: 7194066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Properties and efficacy of a human immunoglobulin M preparation for intravenous administration].
    Stephan W; Dichtelmüller H; Schedel I
    Arzneimittelforschung; 1985; 35(6):933-6. PubMed ID: 4026919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage.
    Schiff RI; Rudd C; Johnson R; Buckley RH
    Clin Immunol Immunopathol; 1984 Apr; 31(1):13-23. PubMed ID: 6421523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemical modification with beta-propiolactone as a general concept for the production of intravenously tolerable immunoglobulin preparations].
    Stephan W
    Beitr Infusionther Klin Ernahr; 1983; 11():20-5. PubMed ID: 6686024
    [No Abstract]   [Full Text] [Related]  

  • 9. A retrospective study of immunoglobulin treatment as part of a multi-factorial therapy in children with acute lymphatic leukemia.
    Kornhuber B
    Arzneimittelforschung; 1981; 31(11):1930-1. PubMed ID: 6797446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vitro behaviour and in vivo efficacy of two 7S-immunoglobulin preparations for intravenous use.
    Stephan W; Dichtelmüller H
    Arzneimittelforschung; 1983; 33(11):1538-40. PubMed ID: 6686449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases.
    Schiff RI; Williams LW; Nelson RP; Buckley RH; Burks W; Good RA
    J Clin Immunol; 1997 Jan; 17(1):21-8. PubMed ID: 9049782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional immunoglobulin therapy.
    Hitzig WH; Müntener U
    Birth Defects Orig Artic Ser; 1975; 11(1):339-42. PubMed ID: 50096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tolerance of beta-propiolactone-treated and UV-irradiated rat serum].
    Sonneborn HH; Stephan W
    Infusionsther Klin Ernahr; 1980 Jun; 7(3):145-7. PubMed ID: 7191834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Longterm therapy with i.v.-gamma-globulin in children (author's transl)].
    Kornhuber B
    Monatsschr Kinderheilkd (1902); 1979 Jan; 127(1):20-2. PubMed ID: 83534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of hylan g-f 20 in Guinea pigs and mice.
    Sasaki M; Miyazaki T; Nakamura T; Takahashi T; Miyauchi S; Iwata H
    J Rheumatol; 2004 May; 31(5):943-50. PubMed ID: 15124255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia.
    Björkander J; Nikoskelainen J; Leibl H; Lanbeck P; Wallvik J; Lumio JT; Braconier JH; Pavlova BG; Birthistle K; Engl W; Walter S; Ehrlich HJ
    Vox Sang; 2006 May; 90(4):286-93. PubMed ID: 16635071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of gammaglobulin preparations on in vitro immunoglobulin production induced by pokeweed mitogen].
    Hashimoto F
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):64-71. PubMed ID: 6201426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination and organ distribution of intravenously administered allogeneic and xenogeneic IgG modifications. (Standard IgG, F (ab)2-fragments and beta-propiolactone treated IgG) in dogs.
    Ring J; Duswald KH; Bachmann T; von Scheel J; Stephan W; Brendel W
    Res Exp Med (Berl); 1978 Sep; 173(3):209-18. PubMed ID: 364571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations.
    Bussone G; Dib H; Dimitrov JD; Camoin L; Broussard C; Tamas N; Guillevin L; Kaveri SV; Mouthon L
    Proteomics; 2009 Apr; 9(8):2253-62. PubMed ID: 19296548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.